EPCAM and cancer: However, cancer research continues to reveal new classes of biologically relevant CTCs with high phenotypic variability and physical heterogeneous features, such as circulating cancer cell hybrids incorporating both hematopoietic and epithelial properties (EpCAM-positive, CD45-positive) [50].